To investigate myocardial velocities in anemic very low-birth weight (VLBW) preterm infants, pre and post red blood cells transfusion using tissue Doppler imaging echocardiography. STUDY DESIGN: Forty-eight VLBW preterm infantsp34 weeks and42 weeks old were prospectively divided: Transfused symptomatic infants (Hematocrit (Hct)o0.30 (n ¼ 32)) and non transfused asymptomatic controls (control 1, Hct 40.30 (n ¼ 9) and control 2, Hct o0.30 (n ¼ 7)). Echocardiography was performed before and 3-5 days after transfusion in the transfused, and the controls were studied at similar intervals. Non parametric tests were used for statistical analysis. RESULT: Left ventricular (LV) systolic velocity increased (transfused (4.6 ± 0.70 vs 6.0 ± 0.65, Po0.01)) as did LV diastolic velocities (Po0.01) without significant difference over time in each control. The percentage change in LV velocity following transfusion correlated negatively (r ¼ 0.36) with pre transfusion Hct. CONCLUSION: There is a significant increase in myocardial performance following transfusion, which is related to the severity of the anemia.
INTRODUCTION
Anemia of prematurity is a common problem in neonatal units. Red blood cell (RBC) transfusions are used to treat symptoms commonly associated with anemia, including persistent apnoeic and bradycardic episodes, poor weight gain, tachycardia and pallor. 1 There has been a recent interest in characterizing myocardial function in preterm infants before and after a transfusion. However, the studies demonstrate conflicting results. Two studies reported a fall in left ventricular output, left ventricular (LV) shortening fraction (SF), and the corrected velocity of circumferential fiber shortening following blood transfusion. 2, 3 A third more recent study reported no change in these parameters. 4 The differing results may be explained by variation in the timing of scans, as these parameters are influenced by changes in ventricular loading, and therefore may not always reflect true myocardial function.
Tissue Doppler imaging (TDI) is a relatively new modality that measures contraction and relaxation velocities of the myocardium. This offers a quantitative assessment of both systolic and diastolic functions by assessing the displacement of the mitral and tricuspid annuli during the cardiac cycle. Systolic function of the left and right ventricular free walls, as well as the intraventricular septum can be assessed by measuring the peak systolic velocity of the myocardial muscle in that region (termed S wave). Diastolic function is obtained by measuring the peak early diastolic velocity (È) and the peak late (or atrial phase) diastolic velocity (À ). This assessment of systolic and diastolic functions is relatively independent of preload, and may enable us to quantify the degree of dysfunction in various disease states and monitor treatment response in preterm infants. [5] [6] [7] The measurement of TDI velocities has been validated in both animal models 8 and in human adult populations. 9 Recent studies show the use of TDI in preterm infants is feasible with acceptable reliability. [10] [11] [12] We hypothesize that tissue hypoxemia secondary to low hematocrit (Hct) affects myocardial function measured by TDI. Restoration of an adequate Hct level may subsequently improve function. Our objective was to assess myocardial function by using TDI before and 3 to 5 days after RBC transfusion, in stable growing preterm infants less than 1501 g.
METHODS
This was prospective observational study conducted at the Rotunda hospital, Dublin, Ireland. The neonatal intensive care unit is a center with B8500 deliveries annually. The local institutional ethical committee approved the study and informed consent was obtained in all cases.
Infants admitted to the neonatal intensive care unit between June 2009 and December 2010, were considered eligible for the study. We included infants less than 34 weeks gestation, less than 1501 g at birth and greater than 2 weeks old at the time of study. Stable preterm infants were considered eligible for the study. We defined stability as follows: more than 2 weeks old without tachypnea (470 breaths per min) and receiving continuous positive airway pressure, supplemental oxygen or in air. Infants of diabetic mothers, infants with a patent ductus arteriosus, congenital heart disease, congenital malformations, suspected or clinically proven sepsis or necrotizing entrocolitis and infants on inotropic support or mechanical ventilation at the time of study, were excluded. The fluid management regimen for this stable preterm population in our neonatal unit ranges between 150 ml kg À 1 per day to 200 ml kg À 1 per day, depending on their growth velocity.
Infants were divided into symptomatic infants requiring a RBC transfusion (patient group) and asymptomatic infants who did not meet the transfusion criteria (controls) as per our neonatal unit guidelines. The controls were divided into two groups based on their Hct. Infants with a Hct 40.30 were labeled control group 1. Infants with a Hct o0.30 were labeled control group 2. Control group 2 were not transfused as they were not significantly apnoeic or bradycardic, had an acceptable weight gain of 150 to 200 g per week before study and did not require significant respiratory support. This was in keeping with our local institutional guidelines. The patient group underwent echocardiography TDI measurements in the 24 h before transfusion and again on day 3 to 5 following transfusion. Each control group had echocardiography measurements made at similar time points to establish the innate variability of TDI in non transfused infants. We included two control groups to demonstrate the difference (if any) in baseline measurements of TDI velocities between non symptomatic infants with a high Hct (40.30) and a low Hct (o0.30), compared with symptomatic anemic infants.
Neither control group received a blood transfusion. The patient group received a RBC transfusion as indicated by our unit guidelines as follows: Hemoglobin (Hb) of p7 gm dl À 1 or Hct of p0.20% regardless of respiratory status; Hb of p10 gm dl À 1 or Hct of p0.30 if on nasal continuous positive airway pressure or on supplemental oxygen with an oxygen requirementX35%. Infants with frequent apnoeic or bradycardic episodes (410 in 24 h), sustained tachycardia 4180 beats per minute for 24 h without clinical evidence of sepsis or poor weight gain in conjunction with a Hct o0.30 were also transfused. The decision to transfuse an infant was at the discretion of the attending neonatologist who was unaware of echocardiographic findings. The administered RBC volume was 20 ml kg 
Clinical variables
The following clinical variables were collected: gestation, birth weight, gender, mode of delivery, apgar score, vital signs (heart rate, blood pressure and axillary temperature), fluid balance (intake and output record), number of desaturations, apnoeic or bradycardic episodes in the 24 h pre and post transfusion, weight gain over the 7-day periods before and post transfusion and overall number of transfusions required.
Echocardiography
The echocardiographic studies were performed by one observer (primary investigator), using a Vivid i, General electrical (7S-RS Probe). The echocardiographer received extensive training in image acquisition and interpretation. A consultant pediatric cardiologist assessed image quality offline. Concurrent electrocardiography tracings were recorded to time cardiac events. A formal structural echocardiogram was performed by a pediatric cardiologist on all infants to rule out the presence of congenital heart disease and patent ductus arteriosus. Measurement of all the functional parameters was performed offline following the completion of the study. For blinding purposes, the pre and post transfusion images were assigned a unique identity, and the observer was unaware of the timing of the study at the time of offline measurements. An apical four-chamber view was obtained to acquire TDI velocities. The pulsed wave Doppler sample gate of 0.35 cm was positioned at the lateral mitral annulus) and lateral tricuspid annulus to obtain peak myocardial systolic (Ś), early (É ) and late (À ) diastolic velocities of the left and right ventricles. An angle of less than 20 1 was maintained and angle correction software was not used. Offline analysis used the average readings of peak S, È and À myocardial velocities in three cardiac cycles. Each TDI measurement was performed by one operator (primary investigator). Parasternal transthoracic, M-mode echocardiography was used to measure LV end-diastolic diameter (LVEDD), LV end-systolic diameter and SF. SF was calculated according to the following formula: ((LVEDD-LV end-systolic diameter/LVEDD) Â 100). At least three consecutive Doppler waveforms were recorded to obtain mean SF values for the LV. Each study was performed within a 5 to 10 minwindow when the subject was quiet and settled. All offline analysis was performed by a single operator (MS).
Statistics
The echocardiographic values are expressed as median and interquartile ranges. The Kruskal-Wallis was used for multiple group comparisons and the Wilcoxon Rank Sign test for paired data was used to detect statistical significance between groups.
The inter-and intra-observer variability of TDI velocities were assessed using 14 infants with similar characteristic to the cohort (mean gestational age of 26.4±1.7 and birth weight of 875±207 g). Intra-observer variability was assessed by one investigator performing offline analysis on the same patients 4 weeks apart to reduce recall bias. Inter-observer variability was assessed by a second investigator, who was blinded to the results of the same set of 14 infants. Inter observer and intra observer agreement was assessed using the intra-class correlation coefficient version 2.1. Additionally, agreement between investigators was demonstrated using the BlandAltman method by calculating the bias (mean difference) and the 95% limits of agreement (1.96 s.d.'s around the mean difference). 13 The results of the reliabiliy of S wave measurement were presented.
RESULTS
Parental consent was obtained to study 60 infants. Twelve infants were subsequently withdrawn from the study as they no longer met the criteria, at the time of study. Six of those infants underwent an evaluation for sepsis, one of which was culture positive. Three infants underwent an evaluation for necrotizing entrocolitis, one of which was proven by imaging. Three infants were transferred to other hospitals before the second echo. A total of 48 infants were included in the analysis. Sixteen infants acted as non symptomatic controls: control group1 (high-Hct group, n ¼ 9) and control group 2 (low-Hct group, n ¼ 7). All study infants remained well and on the same fluid regimen throughout the study as described. Birth weight, gestational and postnatal age was similar in transfused infants and controls ( Table 1) . The symptomatic transfused infants received a higher degree of respiratory support (Po0.05) than asymptomatic controls.
Reliability analysis Intra-and inter-observer reliability was tested for the LV peak systolic velocity (LV S) in the cohort. The Bland-Altman plots demonstrated that 104/116 data points for inter-observer and all but two for intra-observer variability, were well within the upper and lower limits of agreement (( ± 1.96 s.d.), Figures 1a and b] . The mean (s.d.) of inter-and intra-observer difference of each peak LV S was 0.043 (0.375) cm s À 1 and 0.046 (0.323) cm s À 1 , respectively. The intra-class correlation coefficient was 0.845 for inter-observer (95% CI 0.776-0.892) and 0.857 (95% CI 0.752-0.918) for intra-observer values.
Comparison of baseline echo parameters across the three groups Baseline LV S (Figure 2) , È, and À velocities were significantly lower in the patient group vs both control groups (Po0.05 for all parameters). SF reduced and LVEDD was higher in the transfused patient group than the controls at baseline (Po0.001 and 0.003, respectively). Of the right ventricular indices only the È velocity was significantly different at baseline (P 0.006), with lower values in the patient group (Table 2 ).There was a trend towards lower baseline peak velocities in infants requiring respiratory support in the patient group (n ¼ 28) compared with the infants on respiratory support in the combined control groups (n ¼ 9, median (4.7 vs 5.1), IQ (1.27 vs 0.9), P ¼ 0.06).
Comparison of echo parameters pre and post transfusion Both left (LV S as shown in Figure 2 ) and right ventricular peak S, È and À velocities significantly increased following transfusion. In addition, SF significantly increased in the transfused patient group (Table 2 ). There was a statistically significant fall in the LVEDD in the transfused group. There was no significant difference in SF, Anaemia of prematurity and myocardial contractility MS Saleemi et al LVEDD or peak myocardial velocities in either control group over the same interval (Table 2) .
Correlation between Hct and echo parameters
The initial Hct demonstrated a significant positive correlation (Po0.001) with pre transfusion LV S (Figure 3 , Spearman's rho ¼ 0.65). There was also a significant negative correlation between the pre transfusion Hct and the percentage improvement in both LV S (Spearman rho ¼ 0.36, Po0.05) and SF (Spearman rho ¼ 0.30, Po0.05) following transfusion. Ninety-four percent of transfused babies had at least a 10% rise in peak myocardial systolic velocity (S) in the 3 to 5 days after transfusion, however, none of the control infants showed a comparable increase in velocity in the same time period. Both control and post-transfusion patients demonstrated inter-quartile ranges for LV peak myocardial systolic velocity (S) over 45 cm s À 1 . The greatest post-transfusion increase in peak myocardial systolic velocity (S) was seen in those infants with a pre transfusion S of less than 5 cm s À 1 : 79% of these infants had a 420% increase in velocity after transfusion compared with only 25% of those whose initial S exceeded this value.
DISCUSSION
This study demonstrated that tissue Doppler velocities significantly improve following a RBC transfusion in preterm infants with anemia. This improvement was more pronounced in infants with lower pre transfusion myocardial velocities. There was no significant change in myocardial function over a similar time interval in the controls regardless of the baseline Hct. There was no correlation seen between the type of respiratory support and the increase in peak myocardial systolic velocities, although an effect cannot be excluded, as infants receiving nasal continuous positive airway pressure/oxygen had higher pre transfusion Hct readings than infants on room air. A rise in Hct without a change in the effective blood volume leads to an increase in blood viscosity and a resultant increase in afterload. A case report by Sehgal and Francis 14 in 2011, demonstrated an improvement in myocardial performance following a partial exchange transfusion in a neonate with polycythaemia (Hct 40.70). However, although the relationship between Hct and viscosity is linear at normal levels, viscosity increases disproportionately at high-Hct levels, and the increase in viscosity following tranfsusion of anemic infants is unlikely to have any major effect on contractility. 15 There was no significant clinical change in the load-dependent echo parameters (SF and LVEDD) in the patient group following a transfusion. This would suggest that the increase in TDI parameters is secondary to an improvement in myocardial contractility (possibly secondary to improved oxygen delivery) rather than being due to a change in loading conditions. Indeed, all transfused infants received frusemide following the transfusion. We demonstrated that measurement of TDI in the preterm population is feasible and reliable.
Contrary to our findings, two studies have demonstrated a fall in cardiac output or no change in cardiac output following a transfusion. 3, 4 Neither study measured TDI velocities in their patients. They also included infants on mechanical ventilation as well as those with patent ductus arteriosus, both of which may independently affect measurements of cardiac function.
Alkalay et al. 16 studied volume measurements including stroke volume, left ventricular output, LVEDD and LV end-systolic diameter within 48 h of transfusion, but found that they failed to correlate with pre transfusion Hct, and actually increased with more severe anemia. Our study showed a positive correlation between pre transfusion peak myocardial systolic velocities (S) and pre transfusion Hct. This is probably due to the fact that stroke volume, left ventricular output, LVEDD and LV end-systolic diameter all depend on preload, which increases in severe anemia, 17 but TDI is less influenced by loading conditions. 18 TDI assesses systolic and diastolic function of both ventricles relatively independent of preload. Studies in both adults and children show that unlike Doppler assessment of function, such as the E/A wave ratio to assess mitral inflow or LV dimension measures such as SF and corrected velocity of circumferential fiber shortening, direct measurement of muscle velocity is not influenced by volume effects on either chamber size. 19 Eidem et al. 20 demonstrated that mitral, septal and tricuspid tissue Doppler velocities (S, È and À ) were similar in infants with ventricular septal defects, who had evidence of chronic volume overload due to increased preload, when compared with normal matched controls. Sohn et al. 21 demonstrated unchanged S, È and À in healthy volunteers before and after the administration of saline boluses.
When compared with conventional echocardiography markers of function (such as SF), TDI has been shown to detect important changes in myocardial performance at an earlier stage of an active disease process. In young patients with Duchenne muscular dystrophy, who appear to have normal systolic function measured using conventional echocardiography markers (SF), reductions in systolic and early diastolic myocardial velocities (measured using TDI) can be detected in the anterolateral and inferolateral LV walls. 22, 23 Our study demonstrates that infants with the lowest Hct had the lowest myocardial systolic velocities (S) before transfusion and had the greatest increase in peak myocardial systolic (S) velocities after transfusion. These changes were more prominent when the pre transfusion Hct was p0.26. The effects of anemia on the myocardium appear to be less significant in cases of mild anemia, but the myocardium appears to decompensate rapidly at lower Hct levels. Our control group 2 infants had higher baseline TDI values than the infants treated for anemia. This may be accounted for in part that they had a higher mean Hct level than transfused infants. However, it is also possible that the symptoms of anemia that led to transfusion were due to reduced myocardial contractility, and that the level of anemia, at which myocardial contractility is reduced varies from infant to infant.
Two randomised clinical trials 24, 25 concluded that preterm babies received fewer RBC transfusions when using restrictive guidelines. However, these studies produced conflicting results regarding short-term major neurological adverse outcome. 26 In the PINT trial, 24 the transfusion thresholds for the restrictive group ranged between 7.5 to 11.5 gm dl À 1 . The authors suggested that the transfusion thresholds could be moved downward by at least 1 gm dl À 1 , as no difference in outcome was found between the restrictive and liberal transfusion groups. In the Iowa trial, 25 the incidence of neurological complications increased significantly in the restricted group (transfusion thresholds for Hb ranged from 7.3 to 11.3 gm dl À 1 ). They suggested that restrictive criteria for RBC transfusion should be re-examined carefully. The mean gestation and birth weight of infants in both these studies were comparable to our patient cohort. Our criteria for transfusion ranged between Hb of 7.5 to 10 gm À dl À 1 , and our results demonstrated that infants with Hb of o8.5 gm dl À 1 showed the greatest increase in myocardial contractility following transfusion. Data on neurological or short-term outcomes were not collected as part of our observational study; however, there is justification for concern. Hoften et al. 27 concluded that cerebral oxygenation in preterm infants may be at risk when Hb level decreases under 9.7 gm dl À 1 (Hct o0.27). He postulated that anemia might impair oxygen supply, resulting in lower tissue oxygen saturation and a higher fractional tissue oxygen extraction. The median Hct level before transfusion in Hoften's study was 0.31 vs 0.26 in our study population. Our study suggests that transfusion also improves cardiac function, and therefore possibly cerebral perfusion. Further studies are needed to identify the relationship between reduced myocardial contractility, as measured by pre transfusion TDI, and cerebral oxygenation and fractional tissue oxygen extraction in the brain of the anemic preterm infant.
Study limitations
This study used a small sample size, especially in control group 2. It is difficult to perform power calculations, as the normative values for TDI at various gestational and postnatal ages in preterm infants are not well-defined. This is also a limitation in the interpretation of our study results. Thirdly, there may be confounding effects of non invasive respiratory support on cardiac function. However, it is unlikely that continuous positive airway pressure has a deleterious effect on cardiac contractility, as many of our control group 1 infants were on respiratory support, and had high TDI values. The study, however, was not powered to address this question. In addition, the influence of afterload on TDI measurements was unexplored in this study. Although blinded to pre-and post-transfusion status during the data extraction and analysis phases of the study, the primary investigator was not blinded at the time of echocardiogram itself.
CONCLUSIONS
Cardiac function measured by TDI improves following RBC transfusion in anemic preterm infants. The significant increase in myocardial contractility is related to the severity of anemia, although there may still be a minor influence of volume loading. Future studies in preterm infants are warranted to establish normative values for TDI at various gestational and postnatal ages to develop TDI as a clinical tool in the NICU.
